APDN Announces Pricing of $6.5 Million Registered Direct Offering and Concurrent Private Placement
October 30, 2024
Applied DNA to Participate in the 2024 Maxim Healthcare Virtual Summit on Wednesday, October 16
October 15, 2024
Applied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement
September 18, 2024
Linea IVT as High-yield, dsRNA-Mitigated Platform for the GMP Manufacture of RNA
September 17, 2024
Applied DNA Receives Linea DNA Follow-on Order from Global Manufacturer of IVDs for Cancer Diagnostic Application
September 17, 2024
Applied DNA Submits Validation Package to New York State Department of Health toExpand Linea Mpox Virus 1.0 Assay to Mpox Clade I
August 23, 2024
APDN To Submit Application to NYS Dept of Health to Expand Intended Use of Linea Mpox Virus 1.0 Assay to Mpox Clade I
August 23, 2024
Get Social